Description
Vitamin D supplementation outcomes in dementia-related cognitive endpoints are compiled from the included clinical trials.
Cite This Figure
![Figure 2: Vitamin D supplementation outcomes in dementia-related cognitive endpoints are compiled from the included clinical trials.]() > Source: Victoria Gil Martínez et al. "Vitamin Supplementation and Dementia: A Systematic Review.." *Nutrients*, 2022. PMID: [35268010](https://pubmed.ncbi.nlm.nih.gov/35268010/)
<figure> <img src="" alt="Vitamin D supplementation outcomes in dementia-related cognitive endpoints are compiled from the included clinical trials." /> <figcaption>Figure 2. Vitamin D supplementation outcomes in dementia-related cognitive endpoints are compiled from the included clinical trials.<br> Source: Victoria Gil Martínez et al. "Vitamin Supplementation and Dementia: A Systematic Review.." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35268010/">35268010</a></figcaption> </figure>
Related Evidence
A
Omega-3 Fatty Acids (DHA/EPA) for Age-Related Cognitive Decline
B
Grade A · 58 studies
Omega-3 Fatty Acids (DHA/EPA) for Mild Cognitive Impairment (MCI)
B
Grade B · 18 studies
Vitamin B12 for Age-Related Cognitive Decline
C
Grade B · 12 studies
Vitamin E for Age-Related Cognitive Decline
Grade C · 12 studies